Xinping Yang

Dec 19, 2023 | mdpi.com | Ying Zhang |Xinping Yang |Mingliang Fu

All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.

Nov 23, 2023 | mdpi.com | Xinping Yang

This is an early access version, the complete PDF, HTML, and XML versions will be available soon.

Jul 21, 2023 | onlinelibrary.wiley.com | Christian Cuba Samaniego |Jay Friedman |Xinping Yang |Christopher Badger

Abstract Background Treatment of patients with newly diagnosed HPV-associated oropharyngeal squamous cell carcinoma (OPSCC) with neoadjuvant chemotherapy (NAC) results in a high rate of 5-year recurrence free survival with few patients requiring adjuvant treatment. We hypothesized that NAC enhances primary tumor HPV-specific T cell responses. Methods HPV-specific responses in tumor infiltrating lymphocytes (TILs) before and after NAC were determined using autologous co-culture assays.